相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
Joan T. Merrill et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Ethnicity and lupus nephritis: an Australian single centre study
C. Ong et al.
INTERNAL MEDICINE JOURNAL (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
The Efficacy and Safety of Abatacept in Patients With Non-Life-Threatening Manifestations of Systemic Lupus Erythematosus Results of a Twelve-Month, Multicenter, Exploratory, Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial
J. T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Effect of Long-Term Belimumab Treatment on B Cells in Systemic Lupus Erythematosus
Annett M. Jacobi et al.
ARTHRITIS AND RHEUMATISM (2010)
Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
Gabor G. Illei et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices
M. Hegazy et al.
CLINICAL IMMUNOLOGY (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin
Stacey R. Dillon et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus
J. Morel et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
B Lymphocyte Stimulator Expression in Pediatric Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis Patients
Sandy D. Hong et al.
ARTHRITIS AND RHEUMATISM (2009)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus
Daniel J. Wallace et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications
Dongsheng Gu et al.
AUTOIMMUNITY (2009)
Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets
Jennifer H. Anolik et al.
IMMUNOLOGIC RESEARCH (2009)
Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells
Esra Ozcan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expression
Zev M. Sthoeger et al.
JOURNAL OF AUTOIMMUNITY (2009)
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
Michael P. Cancro et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
IFN-α amplifies human naive B cell TLR-9-mediated activation and Ig production
L. Giordani et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
C. Pena-Rossi et al.
LUPUS (2009)
Adverse events and efficacy of TNF-α blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients
Martin Aringer et al.
RHEUMATOLOGY (2009)
Anti-CD20 therapy in patients with rheumatoid arthritis -: Predictors of response and B cell subset regeneration after repeated treatment
Petra Roll et al.
ARTHRITIS AND RHEUMATISM (2008)
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2008)
Spliceosomal Peptide P140 for Immunotherapy of Systemic Lupus Erythematosus Results of an Early Phase II Clinical Trial
Sylviane Muller et al.
ARTHRITIS AND RHEUMATISM (2008)
Abetimus sodium for renal flare in systemic lupus erythematosus
Mario H. Cardiel et al.
ARTHRITIS AND RHEUMATISM (2008)
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus
Frances Rena Bahjat et al.
ARTHRITIS AND RHEUMATISM (2008)
Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
A. Komatsuda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways
Marc Ittah et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The innate immune system in SLE: type I interferons and dendritic cells
L. Roennblom et al.
LUPUS (2008)
Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms
Annie George-Chandy et al.
ARTHRITIS RESEARCH & THERAPY (2008)
B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response
G. Cambridge et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice
David J. DiLillo et al.
JOURNAL OF IMMUNOLOGY (2008)
Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus
Maria Dall'Era et al.
ARTHRITIS AND RHEUMATISM (2007)
Depletion of B cells in murine lupus: Efficacy and resistance
Anupama Ahuja et al.
JOURNAL OF IMMUNOLOGY (2007)
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
Joanna R. Groom et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid
R. Watanabe et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2007)
Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy
Jennifer H. Anolik et al.
ARTHRITIS AND RHEUMATISM (2007)
A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis
M. Thangarajh et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus - Findings of a prospective, randomized, double-blind, placebo-controlled trial
Chung-E Tseng et al.
ARTHRITIS AND RHEUMATISM (2006)
Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus - Implications for the induction and maintenance of the autoimmune process
Eva D. Papadimitraki et al.
ARTHRITIS AND RHEUMATISM (2006)
Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus
Bailin Liang et al.
IMMUNOLOGY (2006)
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus
Sean R. Christensen et al.
IMMUNITY (2006)
Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus
David Fernandez et al.
ARTHRITIS AND RHEUMATISM (2006)
An APRIL to remember: novel TNF ligands as therapeutic targets
SR Dillon et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment - Relationships with B cell depletion, circulating antibodies, and clinical relapse
G Cambridge et al.
ARTHRITIS AND RHEUMATISM (2006)
Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor)
TG Cachero et al.
BIOCHEMISTRY (2006)
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
Therese Vallerskog et al.
ARTHRITIS RESEARCH & THERAPY (2006)
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome
Marc Ittah et al.
ARTHRITIS RESEARCH & THERAPY (2006)
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels
CE Collins et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
Thomas Doerner et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
EM Ginzler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Follicular B helper T cells in antibody responses and autoimmunity
CG Vinuesa et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease
N Yazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Raised serum APRIL levels in patients with systemic lupus erythematosus
T Koyama et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
ΔBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models
AL Gavin et al.
JOURNAL OF IMMUNOLOGY (2005)
A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity
CG Vinuesa et al.
NATURE (2005)
BAFF augments certain Th1-associated inflammatory responses
APR Sutherland et al.
JOURNAL OF IMMUNOLOGY (2005)
Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome
MV Jonsson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2005)
Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type IFN
IB Bekeredjian-Ding et al.
JOURNAL OF IMMUNOLOGY (2005)
IFN-α induces early lethal lupus in preautoimmune (New Zealand black x New Zealand White)F1 but not in BALB/c mice
A Mathian et al.
JOURNAL OF IMMUNOLOGY (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy
Q Gong et al.
JOURNAL OF IMMUNOLOGY (2005)
Distinct profiles of human B cell effector cytokines: A role in immune regulation?
ME Duddy et al.
JOURNAL OF IMMUNOLOGY (2004)
Sequential therapies for proliferative lupus nephritis
G Contreras et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
T cells in the pathogenesis of systemic lupus erythematosus
RW Hoffman
CLINICAL IMMUNOLOGY (2004)
Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus -: An open-label study
M Aringer et al.
ARTHRITIS AND RHEUMATISM (2004)
Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus
W Stohl et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus
M Ramanujam et al.
JOURNAL OF IMMUNOLOGY (2004)
Dysfunctional B cells in systemic lupus erythematosus
Y Renaudineau et al.
AUTOIMMUNITY REVIEWS (2004)
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches
M Thien et al.
IMMUNITY (2004)
A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation
D Luger et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
KP Baker et al.
ARTHRITIS AND RHEUMATISM (2003)
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
MR Arbuckle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
ΔBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF
AL Gavin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells
J Lund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis
DT Boumpas et al.
ARTHRITIS AND RHEUMATISM (2003)
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/Ipr mice
F Monneaux et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus - Longitudinal observations
W Stohl et al.
ARTHRITIS AND RHEUMATISM (2003)
Systemic lupus erythematosus in the far north of Queensland
D Bossingham
LUPUS (2003)
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154 - A randomized, double-blind, placebo-controlled trial
KC Kalunian et al.
ARTHRITIS AND RHEUMATISM (2002)
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases
V Roschke et al.
JOURNAL OF IMMUNOLOGY (2002)
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2
N Kayagaki et al.
IMMUNITY (2002)
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
MB Litinskiy et al.
NATURE IMMUNOLOGY (2002)
Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators
BL Hsu et al.
JOURNAL OF IMMUNOLOGY (2002)
Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands
YF Liu et al.
CELL (2002)
Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen
P Schneider et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice
H Wang et al.
NATURE IMMUNOLOGY (2001)
Regulation of the T-independent humoral response by TACI
GU von Bülow et al.
IMMUNITY (2001)
Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide
DI Daikh et al.
JOURNAL OF IMMUNOLOGY (2001)
Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus
J Zhang et al.
JOURNAL OF IMMUNOLOGY (2001)
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli et al.
BLOOD (2001)
BAFF mediates survival of peripheral immature B lymphocytes
M Batten et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice
C Mary et al.
JOURNAL OF IMMUNOLOGY (2000)
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
JA Gross et al.
NATURE (2000)
分享论文
